Lung Cancer Tumor Molecular Profiling
Learn More About Tumor Molecular Profiling for Lung Cancer: Chat with Us | Email Us
Video: Molecular Testing
Dr. Ritwick Panicker, a medical oncologist and hematologist at Cancer Treatment Centers of America, explains molecular testing and how it enables doctors to personalize cancer treatment.Molecular Testing
Dr. Ritwick Panicker, a medical oncologist and hematologist at Cancer Treatment Centers of America, explains molecular testing and how it enables doctors to personalize cancer treatment.
Tumor Molecular Profiling for Lung Cancer
Prior to delivering chemotherapy, the lung cancer team at Cancer Treatment Centers of America (CTCA) conducts tumor molecular profiling. This helps us determine the right combination of chemotherapy drugs to use for your particular type of lung cancer.
In this test, a sample of the tumor is removed and tested for a variety of enzymes, proteins and genes to identify which therapies are likely to be most effective.
We use CarisTarget Now™ Molecular Profiling, a comprehensive tumor analysis test that matches therapies to your specific biomarker information to develop an evidence-based treatment plan. By allowing us to choose more effective drugs from the start, tumor molecular profiling can help you avoid unnecessary toxicity, and lets us target cancer cells as aggressively as possible.
Next Topic: Metronomic Chemotherapy for Lung Cancer
